loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 21001 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ALMOTRIPTAN MALATE (2)

filter

01 JANSSEN PHARMS (2)

filter

01 TABLET;ORAL (2)

filter

01 EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

02 EQ 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

filter

01 USA (2)

URL Supplier Web Content
TABLET;ORAL
EQ 6.25MG BASE **Feder...
AXERT
USA
21001
2001-05-07
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
EQ 12.5MG BASE **Feder...
AXERT
USA
21001
2001-05-07
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 21001

Looking for CTD TGA MCC DOSSIER APPLICATION 21001 2

19

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ALMOTRIPTAN MALATE, with a corresponding application number 21001 and regulatory information .

proudly manufactured in the

approval since 2001-05-07

Johnson & Johnson Innovative Medicine's AXERT TABLET;ORAL, medication with EQ 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ALMOTRIPTAN MALATE.

18

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ALMOTRIPTAN MALATE, with a corresponding application number 21001 and regulatory information .

proudly manufactured in the

approval since 2001-05-07

Johnson & Johnson Innovative Medicine's AXERT TABLET;ORAL, medication with EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ALMOTRIPTAN MALATE.

Post Enquiry
POST ENQUIRY